[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Intermittent Claudication Market Growth (Status and Outlook) 2024-2030

June 2024 | 103 pages | ID: G742B6C38368EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Intermittent Claudication market size was valued at US$ million in 2023. With growing demand in downstream market, the Intermittent Claudication is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Intermittent Claudication market. Intermittent Claudication are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Intermittent Claudication. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Intermittent Claudication market.

Intermittent claudication is a type of muscle pain especially in calf muscle during exercise, such as walking, and is relieved by a short period of rest due to lack of blood supply.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Intermittent Claudication market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Intermittent Claudication market. It may include historical data, market segmentation by Type (e.g., Medication Therapies, Revascularization), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Intermittent Claudication market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Intermittent Claudication market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Intermittent Claudication industry. This include advancements in Intermittent Claudication technology, Intermittent Claudication new entrants, Intermittent Claudication new investment, and other innovations that are shaping the future of Intermittent Claudication.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Intermittent Claudication market. It includes factors influencing customer ' purchasing decisions, preferences for Intermittent Claudication product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Intermittent Claudication market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Intermittent Claudication market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Intermittent Claudication market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Intermittent Claudication industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Intermittent Claudication market.

Market Segmentation:

Intermittent Claudication market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • by Treatment Process
    • Medication Therapies
    • Revascularization
  • by Drug Type
    • ALD-301
    • DVC1-0101
    • K-134
    • LT-0101
    • PLX-PAD
    • Tirasemtiv
Segmentation by application
  • Hospitals
  • Clinics
  • Home Healthcare
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • I'ROM GROUP(DNAVEC Corporation)
  • Nuo Therapeutics Inc.
  • Kowa Company Ltd.
  • LTT Bio-Pharma
  • Pluristem Therapeutics Inc.
  • Nuo Therapeutics, Inc.(Aldagen, Inc.)
  • Genovate Biotechnology Co., Ltd.
  • Novartis AG
  • ID Pharma Co., Ltd
  • Helixmith Co., Ltd.
  • G. Pohl-Boskamp GmbH & Co. KG
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Intermittent Claudication Market Size 2019-2030
  2.1.2 Intermittent Claudication Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Intermittent Claudication Segment by Type
  2.2.1 Medication Therapies
  2.2.2 Revascularization
2.3 Intermittent Claudication Market Size by Type
  2.3.1 Intermittent Claudication Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Intermittent Claudication Market Size Market Share by Type (2019-2024)
2.4 Intermittent Claudication Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Home Healthcare
  2.4.4 Others
2.5 Intermittent Claudication Market Size by Application
  2.5.1 Intermittent Claudication Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Intermittent Claudication Market Size Market Share by Application (2019-2024)

3 INTERMITTENT CLAUDICATION MARKET SIZE BY PLAYER

3.1 Intermittent Claudication Market Size Market Share by Players
  3.1.1 Global Intermittent Claudication Revenue by Players (2019-2024)
  3.1.2 Global Intermittent Claudication Revenue Market Share by Players (2019-2024)
3.2 Global Intermittent Claudication Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INTERMITTENT CLAUDICATION BY REGIONS

4.1 Intermittent Claudication Market Size by Regions (2019-2024)
4.2 Americas Intermittent Claudication Market Size Growth (2019-2024)
4.3 APAC Intermittent Claudication Market Size Growth (2019-2024)
4.4 Europe Intermittent Claudication Market Size Growth (2019-2024)
4.5 Middle East & Africa Intermittent Claudication Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Intermittent Claudication Market Size by Country (2019-2024)
5.2 Americas Intermittent Claudication Market Size by Type (2019-2024)
5.3 Americas Intermittent Claudication Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Intermittent Claudication Market Size by Region (2019-2024)
6.2 APAC Intermittent Claudication Market Size by Type (2019-2024)
6.3 APAC Intermittent Claudication Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Intermittent Claudication by Country (2019-2024)
7.2 Europe Intermittent Claudication Market Size by Type (2019-2024)
7.3 Europe Intermittent Claudication Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Intermittent Claudication by Region (2019-2024)
8.2 Middle East & Africa Intermittent Claudication Market Size by Type (2019-2024)
8.3 Middle East & Africa Intermittent Claudication Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INTERMITTENT CLAUDICATION MARKET FORECAST

10.1 Global Intermittent Claudication Forecast by Regions (2025-2030)
  10.1.1 Global Intermittent Claudication Forecast by Regions (2025-2030)
  10.1.2 Americas Intermittent Claudication Forecast
  10.1.3 APAC Intermittent Claudication Forecast
  10.1.4 Europe Intermittent Claudication Forecast
  10.1.5 Middle East & Africa Intermittent Claudication Forecast
10.2 Americas Intermittent Claudication Forecast by Country (2025-2030)
  10.2.1 United States Intermittent Claudication Market Forecast
  10.2.2 Canada Intermittent Claudication Market Forecast
  10.2.3 Mexico Intermittent Claudication Market Forecast
  10.2.4 Brazil Intermittent Claudication Market Forecast
10.3 APAC Intermittent Claudication Forecast by Region (2025-2030)
  10.3.1 China Intermittent Claudication Market Forecast
  10.3.2 Japan Intermittent Claudication Market Forecast
  10.3.3 Korea Intermittent Claudication Market Forecast
  10.3.4 Southeast Asia Intermittent Claudication Market Forecast
  10.3.5 India Intermittent Claudication Market Forecast
  10.3.6 Australia Intermittent Claudication Market Forecast
10.4 Europe Intermittent Claudication Forecast by Country (2025-2030)
  10.4.1 Germany Intermittent Claudication Market Forecast
  10.4.2 France Intermittent Claudication Market Forecast
  10.4.3 UK Intermittent Claudication Market Forecast
  10.4.4 Italy Intermittent Claudication Market Forecast
  10.4.5 Russia Intermittent Claudication Market Forecast
10.5 Middle East & Africa Intermittent Claudication Forecast by Region (2025-2030)
  10.5.1 Egypt Intermittent Claudication Market Forecast
  10.5.2 South Africa Intermittent Claudication Market Forecast
  10.5.3 Israel Intermittent Claudication Market Forecast
  10.5.4 Turkey Intermittent Claudication Market Forecast
  10.5.5 GCC Countries Intermittent Claudication Market Forecast
10.6 Global Intermittent Claudication Forecast by Type (2025-2030)
10.7 Global Intermittent Claudication Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 I'ROM GROUP(DNAVEC Corporation)
  11.1.1 I'ROM GROUP(DNAVEC Corporation) Company Information
  11.1.2 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product Offered
  11.1.3 I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 I'ROM GROUP(DNAVEC Corporation) Main Business Overview
  11.1.5 I'ROM GROUP(DNAVEC Corporation) Latest Developments
11.2 Nuo Therapeutics Inc.
  11.2.1 Nuo Therapeutics Inc. Company Information
  11.2.2 Nuo Therapeutics Inc. Intermittent Claudication Product Offered
  11.2.3 Nuo Therapeutics Inc. Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Nuo Therapeutics Inc. Main Business Overview
  11.2.5 Nuo Therapeutics Inc. Latest Developments
11.3 Kowa Company Ltd.
  11.3.1 Kowa Company Ltd. Company Information
  11.3.2 Kowa Company Ltd. Intermittent Claudication Product Offered
  11.3.3 Kowa Company Ltd. Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Kowa Company Ltd. Main Business Overview
  11.3.5 Kowa Company Ltd. Latest Developments
11.4 LTT Bio-Pharma
  11.4.1 LTT Bio-Pharma Company Information
  11.4.2 LTT Bio-Pharma Intermittent Claudication Product Offered
  11.4.3 LTT Bio-Pharma Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 LTT Bio-Pharma Main Business Overview
  11.4.5 LTT Bio-Pharma Latest Developments
11.5 Pluristem Therapeutics Inc.
  11.5.1 Pluristem Therapeutics Inc. Company Information
  11.5.2 Pluristem Therapeutics Inc. Intermittent Claudication Product Offered
  11.5.3 Pluristem Therapeutics Inc. Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Pluristem Therapeutics Inc. Main Business Overview
  11.5.5 Pluristem Therapeutics Inc. Latest Developments
11.6 Nuo Therapeutics, Inc.(Aldagen, Inc.)
  11.6.1 Nuo Therapeutics, Inc.(Aldagen, Inc.) Company Information
  11.6.2 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product Offered
  11.6.3 Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Nuo Therapeutics, Inc.(Aldagen, Inc.) Main Business Overview
  11.6.5 Nuo Therapeutics, Inc.(Aldagen, Inc.) Latest Developments
11.7 Genovate Biotechnology Co., Ltd.
  11.7.1 Genovate Biotechnology Co., Ltd. Company Information
  11.7.2 Genovate Biotechnology Co., Ltd. Intermittent Claudication Product Offered
  11.7.3 Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Genovate Biotechnology Co., Ltd. Main Business Overview
  11.7.5 Genovate Biotechnology Co., Ltd. Latest Developments
11.8 Novartis AG
  11.8.1 Novartis AG Company Information
  11.8.2 Novartis AG Intermittent Claudication Product Offered
  11.8.3 Novartis AG Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Novartis AG Main Business Overview
  11.8.5 Novartis AG Latest Developments
11.9 ID Pharma Co., Ltd
  11.9.1 ID Pharma Co., Ltd Company Information
  11.9.2 ID Pharma Co., Ltd Intermittent Claudication Product Offered
  11.9.3 ID Pharma Co., Ltd Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 ID Pharma Co., Ltd Main Business Overview
  11.9.5 ID Pharma Co., Ltd Latest Developments
11.10 Helixmith Co., Ltd.
  11.10.1 Helixmith Co., Ltd. Company Information
  11.10.2 Helixmith Co., Ltd. Intermittent Claudication Product Offered
  11.10.3 Helixmith Co., Ltd. Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Helixmith Co., Ltd. Main Business Overview
  11.10.5 Helixmith Co., Ltd. Latest Developments
11.11 G. Pohl-Boskamp GmbH & Co. KG
  11.11.1 G. Pohl-Boskamp GmbH & Co. KG Company Information
  11.11.2 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product Offered
  11.11.3 G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 G. Pohl-Boskamp GmbH & Co. KG Main Business Overview
  11.11.5 G. Pohl-Boskamp GmbH & Co. KG Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Intermittent Claudication Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Medication Therapies
Table 3. Major Players of Revascularization
Table 4. Intermittent Claudication Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Intermittent Claudication Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Intermittent Claudication Market Size Market Share by Type (2019-2024)
Table 7. Intermittent Claudication Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Intermittent Claudication Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Intermittent Claudication Market Size Market Share by Application (2019-2024)
Table 10. Global Intermittent Claudication Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Intermittent Claudication Revenue Market Share by Player (2019-2024)
Table 12. Intermittent Claudication Key Players Head office and Products Offered
Table 13. Intermittent Claudication Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Intermittent Claudication Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Intermittent Claudication Market Size Market Share by Regions (2019-2024)
Table 18. Global Intermittent Claudication Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Intermittent Claudication Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Intermittent Claudication Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Intermittent Claudication Market Size Market Share by Country (2019-2024)
Table 22. Americas Intermittent Claudication Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Intermittent Claudication Market Size Market Share by Type (2019-2024)
Table 24. Americas Intermittent Claudication Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Intermittent Claudication Market Size Market Share by Application (2019-2024)
Table 26. APAC Intermittent Claudication Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Intermittent Claudication Market Size Market Share by Region (2019-2024)
Table 28. APAC Intermittent Claudication Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Intermittent Claudication Market Size Market Share by Type (2019-2024)
Table 30. APAC Intermittent Claudication Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Intermittent Claudication Market Size Market Share by Application (2019-2024)
Table 32. Europe Intermittent Claudication Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Intermittent Claudication Market Size Market Share by Country (2019-2024)
Table 34. Europe Intermittent Claudication Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Intermittent Claudication Market Size Market Share by Type (2019-2024)
Table 36. Europe Intermittent Claudication Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Intermittent Claudication Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Intermittent Claudication Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Intermittent Claudication Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Intermittent Claudication Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Intermittent Claudication Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Intermittent Claudication Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Intermittent Claudication Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Intermittent Claudication
Table 45. Key Market Challenges & Risks of Intermittent Claudication
Table 46. Key Industry Trends of Intermittent Claudication
Table 47. Global Intermittent Claudication Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Intermittent Claudication Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Intermittent Claudication Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Intermittent Claudication Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. I'ROM GROUP(DNAVEC Corporation) Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 52. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Product Offered
Table 53. I'ROM GROUP(DNAVEC Corporation) Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. I'ROM GROUP(DNAVEC Corporation) Main Business
Table 55. I'ROM GROUP(DNAVEC Corporation) Latest Developments
Table 56. Nuo Therapeutics Inc. Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 57. Nuo Therapeutics Inc. Intermittent Claudication Product Offered
Table 58. Nuo Therapeutics Inc. Main Business
Table 59. Nuo Therapeutics Inc. Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Nuo Therapeutics Inc. Latest Developments
Table 61. Kowa Company Ltd. Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 62. Kowa Company Ltd. Intermittent Claudication Product Offered
Table 63. Kowa Company Ltd. Main Business
Table 64. Kowa Company Ltd. Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Kowa Company Ltd. Latest Developments
Table 66. LTT Bio-Pharma Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 67. LTT Bio-Pharma Intermittent Claudication Product Offered
Table 68. LTT Bio-Pharma Main Business
Table 69. LTT Bio-Pharma Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. LTT Bio-Pharma Latest Developments
Table 71. Pluristem Therapeutics Inc. Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 72. Pluristem Therapeutics Inc. Intermittent Claudication Product Offered
Table 73. Pluristem Therapeutics Inc. Main Business
Table 74. Pluristem Therapeutics Inc. Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pluristem Therapeutics Inc. Latest Developments
Table 76. Nuo Therapeutics, Inc.(Aldagen, Inc.) Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 77. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Product Offered
Table 78. Nuo Therapeutics, Inc.(Aldagen, Inc.) Main Business
Table 79. Nuo Therapeutics, Inc.(Aldagen, Inc.) Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Nuo Therapeutics, Inc.(Aldagen, Inc.) Latest Developments
Table 81. Genovate Biotechnology Co., Ltd. Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 82. Genovate Biotechnology Co., Ltd. Intermittent Claudication Product Offered
Table 83. Genovate Biotechnology Co., Ltd. Main Business
Table 84. Genovate Biotechnology Co., Ltd. Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Genovate Biotechnology Co., Ltd. Latest Developments
Table 86. Novartis AG Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 87. Novartis AG Intermittent Claudication Product Offered
Table 88. Novartis AG Main Business
Table 89. Novartis AG Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Novartis AG Latest Developments
Table 91. ID Pharma Co., Ltd Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 92. ID Pharma Co., Ltd Intermittent Claudication Product Offered
Table 93. ID Pharma Co., Ltd Main Business
Table 94. ID Pharma Co., Ltd Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. ID Pharma Co., Ltd Latest Developments
Table 96. Helixmith Co., Ltd. Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 97. Helixmith Co., Ltd. Intermittent Claudication Product Offered
Table 98. Helixmith Co., Ltd. Main Business
Table 99. Helixmith Co., Ltd. Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Helixmith Co., Ltd. Latest Developments
Table 101. G. Pohl-Boskamp GmbH & Co. KG Details, Company Type, Intermittent Claudication Area Served and Its Competitors
Table 102. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Product Offered
Table 103. G. Pohl-Boskamp GmbH & Co. KG Intermittent Claudication Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. G. Pohl-Boskamp GmbH & Co. KG Main Business
Table 105. G. Pohl-Boskamp GmbH & Co. KG Latest Developments

LIST OF FIGURES

Figure 1. Intermittent Claudication Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Intermittent Claudication Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Intermittent Claudication Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Intermittent Claudication Sales Market Share by Country/Region (2023)
Figure 8. Intermittent Claudication Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Intermittent Claudication Market Size Market Share by Type in 2023
Figure 10. Intermittent Claudication in Hospitals
Figure 11. Global Intermittent Claudication Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Intermittent Claudication in Clinics
Figure 13. Global Intermittent Claudication Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Intermittent Claudication in Home Healthcare
Figure 15. Global Intermittent Claudication Market: Home Healthcare (2019-2024) & ($ Millions)
Figure 16. Intermittent Claudication in Others
Figure 17. Global Intermittent Claudication Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Intermittent Claudication Market Size Market Share by Application in 2023
Figure 19. Global Intermittent Claudication Revenue Market Share by Player in 2023
Figure 20. Global Intermittent Claudication Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Intermittent Claudication Market Size 2019-2024 ($ Millions)
Figure 22. APAC Intermittent Claudication Market Size 2019-2024 ($ Millions)
Figure 23. Europe Intermittent Claudication Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Intermittent Claudication Market Size 2019-2024 ($ Millions)
Figure 25. Americas Intermittent Claudication Value Market Share by Country in 2023
Figure 26. United States Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Intermittent Claudication Market Size Market Share by Region in 2023
Figure 31. APAC Intermittent Claudication Market Size Market Share by Type in 2023
Figure 32. APAC Intermittent Claudication Market Size Market Share by Application in 2023
Figure 33. China Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Intermittent Claudication Market Size Market Share by Country in 2023
Figure 40. Europe Intermittent Claudication Market Size Market Share by Type (2019-2024)
Figure 41. Europe Intermittent Claudication Market Size Market Share by Application (2019-2024)
Figure 42. Germany Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Intermittent Claudication Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Intermittent Claudication Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Intermittent Claudication Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Intermittent Claudication Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 56. APAC Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 57. Europe Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 59. United States Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 60. Canada Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 63. China Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 64. Japan Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 65. Korea Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 67. India Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 68. Australia Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 69. Germany Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 70. France Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 71. UK Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 72. Italy Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 73. Russia Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 74. Spain Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 77. Israel Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Intermittent Claudication Market Size 2025-2030 ($ Millions)
Figure 80. Global Intermittent Claudication Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Intermittent Claudication Market Size Market Share Forecast by Application (2025-2030)


More Publications